Parmax Pharma is currently trading at Rs. 15.95, up by 0.75 points or 4.93% from its previous closing of Rs. 15.95 on the BSE.
The scrip opened at Rs. 15.95 and has touched a high and low of Rs. 15.95 and Rs. 15.95 respectively. So far 1466 shares were traded on the counter.
The BSE group 'XT' stock of face value Rs. 10 has touched a 52 week high of Rs. 19.95 on 25-Nov-2019 and a 52 week low of Rs. 15.20 on 23-Apr-2020.
Last one week high and low of the scrip stood at Rs. 16.00 and Rs. 15.20 respectively. The current market cap of the company is Rs. 5.97 crore.
The promoters holding in the company stood at 30.80% and Non-Institutions held at 69.20% respectively.
Parmax Pharma has entered into Confidentiality Agreement with Cadila Healthcare (CHL), Ahmedabad for production of intermediates of ‘Hydroxy chloroquine’ (Product) on the basis of process and specifications provided by the CHL. Currently, company is reviewing the business and taking trial batches of the product.
Parmax Pharma carries on business as manufacturers, producers, refiners, mixers, processors, repackers, distillers, formulators, convertors, extractors, buyers, sellers, wholesalers, retailers, distributors, suppliers, importers, extractors, or otherwise to deal in all kinds of drug and drugs used in pharmaceutical.
